from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1473/-

LFCtreatmentdescriptionclass of inhibitor

-0.478

Amikacinug/mL Amikacintranslation

2.711

Cap5-10ug/mL Capreomycintranslation

1.348

Rox10-50 ug/mL Roxithromycintranslation

1.443

SM2-5 ug/mL Streptomycintranslation

3.025

Tet5-10 ug/mL Tetracyclinetranslation

0.646

Rif0.2-5ug/mL Rifampicintranscription

0.070

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.054

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.099

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.098

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.572

Clofazimine10-13 ug/mL Clofaziminerespiration

0.211

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.014

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.290

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.406

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.402

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.672

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.267

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.327

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.012

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.384

KCN5-20 ug/mL Potassium cyaniderespiration

-0.603

NaN30.2-2 mM Sodium aziderespiration

-1.403

Nigericin50 uM Nigericinrespiration

-0.453

TRC10-150 ug/mL Triclosanrespiration

0.328

TRZ10-25 ug/mL Thioridazinerespiration

-0.394

Valinomycin0.5-10 uM Valinomycinrespiration

-0.659

ZnSO42 mM ZnSO4respiration

-0.149

menadione6-10 ug/mL Menadionerespiration

-0.690

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.430

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.368

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.938

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.038

NRP_1Non-replicating persistence stage 1dosRassociated

-0.446

Amp0.2mg/mL AmpicillincellWall

-0.092

Cephalexin20-100 ug/mL CephalexincellWall

-0.316

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.626

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.500

EMB10-20 ug/mL EthambutolcellWall

-0.186

Eta12-40 ug/mL EthionamidecellWall

0.150

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.229

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.374

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.259

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.096

BZA0.12 mg/mL BenzamidearomaticAmides

-0.103

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.684

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.456

H2O24 mM hydrogen peroxideDNAdamaging

-0.615

Levo10 ug/mL LevofloxacinDNAdamaging

0.561

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.462

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.347

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.104

UVUV-irradiationDNAdamaging

2.808

ARP41-4 ug/mL Antitubercular compound ARP4?

0.087

Antimycin12.5-50 ug/mL Antimycin A?

-0.734

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.096

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.116

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.688

PA8240.2-2 ug/mL PA-824?

-1.670

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.250

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.449

Verapamil50 uM Verapamil?

0.000

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.461

methoxatin10-20 ug/mL Methoxatin?